| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/09/2012 | CA2807127A1 Covalent diabodies and uses thereof |
| 02/09/2012 | CA2807093A1 Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase |
| 02/09/2012 | CA2806829A1 Bone-targeting bisphosphonate duplex drugs |
| 02/09/2012 | CA2806825A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 02/09/2012 | CA2806660A1 Compositions and methods for enhancing the effectiveness of systemic, hipec, ip, and related cancer treatments |
| 02/09/2012 | CA2806190A1 N-acylsulfonamide apoptosis promoters |
| 02/09/2012 | CA2805827A1 Chemical compounds |
| 02/09/2012 | CA2805265A1 Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina) |
| 02/09/2012 | CA2805075A1 Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one chamomilla plant for the treatment of cancer |
| 02/08/2012 | EP2415870A1 Rnai molecule for thymidylate synthase and use thereof |
| 02/08/2012 | EP2415869A1 Modified oligo-nucleic acid molecule, preparation method and uses thereof |
| 02/08/2012 | EP2415785A1 Novel antibodies inhibiting C-Met dimerization, and uses thereof |
| 02/08/2012 | EP2415784A1 Novel antibodies inhibiting C-Met dimerization, and uses thereof |
| 02/08/2012 | EP2415782A1 Compounds stimulating undesirable cellular adhesion and applications thereof |
| 02/08/2012 | EP2415781A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof |
| 02/08/2012 | EP2415780A1 Synthetic peptide and uses thereof |
| 02/08/2012 | EP2415768A1 Tricyclic condensed heterocyclic compound, method for producing same, and use thereof |
| 02/08/2012 | EP2415767A1 Poly (ADP-ribose) Polymerase (PARP) Inhibitors |
| 02/08/2012 | EP2415755A1 Plasminogen activator inhibitor-1 inhibitor |
| 02/08/2012 | EP2415748A1 Novel anti-inflammatory compounds |
| 02/08/2012 | EP2415486A2 Conjugates and compositions for cellular delivery |
| 02/08/2012 | EP2415482A2 Pharmaceutical compositions for treating metastasis |
| 02/08/2012 | EP2415468A1 Composition for alleviating ultraviolet radiation-induced damage |
| 02/08/2012 | EP2414546A2 Compositions and methods for treating or preventing inflammatory bowel disease and colon cancer |
| 02/08/2012 | EP2414399A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use |
| 02/08/2012 | EP2414398A2 Antibodies against human tweak and uses thereof |
| 02/08/2012 | EP2414395A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use |
| 02/08/2012 | EP2414392A2 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same |
| 02/08/2012 | EP2414389A1 Tumor targeting peptides, therapeutic and diagnostic compositions comprising the peptides |
| 02/08/2012 | EP2414385A2 Compositions and methods for modulating the activity of complement regulatory proteins on target cells |
| 02/08/2012 | EP2414383A1 C6orf167 peptides and vaccines containing the same |
| 02/08/2012 | EP2414362A1 Pyrimidine substituted purine compounds as kinase (s) inhibitors |
| 02/08/2012 | EP2414361A1 Substituted heterocyclic compounds |
| 02/08/2012 | EP2414360A1 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds |
| 02/08/2012 | EP2414359A1 Peri-fused pyrazolo-pyrimidine compounds |
| 02/08/2012 | EP2414358A1 Substituted tetrahydropyrazolo-pyrido-azepin compounds |
| 02/08/2012 | EP2414357A1 Pyrazolo-pyrrolopyridine-dione derivatives useful in the treatment of cancer |
| 02/08/2012 | EP2414356A2 Propane- i-sulfonic acid {3- [5- (4 -chloro-phenyl) -1h-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof |
| 02/08/2012 | EP2414349A1 3-ý1,4¨oxazepane-4-pyrimidone derivatives |
| 02/08/2012 | EP2414346A1 Autotaxin inhibitors |
| 02/08/2012 | EP2414344A1 Substituted indolo-pyridinone compounds |
| 02/08/2012 | EP2414338A1 Salts and hydrates of 4-[(3-chlor-4-fluoro-phenyl)amino]-6-(cis-4-{n-[(morph-1-olino-4-yl)carbonyl]-n-methyl-amino}-cyclohexane-1-yloxy)-7-methoxy-quinazoline, their use as drugs and their production |
| 02/08/2012 | EP2414330A2 Piperidine and piperazine derivatives as autotaxin inhibitors |
| 02/08/2012 | EP2414328A2 Dihydroorotate dehydrogenase inhibitors |
| 02/08/2012 | EP2414327A1 Heterocyclic compounds as autotaxin inhibitors |
| 02/08/2012 | EP2413973A1 Polymeric conjugates of paclitaxel and docetaxel with ph-controlled releasing of the cancerostatic agent |
| 02/08/2012 | EP2413968A1 Semaphorin 3c (sema3c) inhibitor therapeutics, methods, and uses |
| 02/08/2012 | EP2413965A1 Treatment of cancer with a humanized anti-egfr igg1 antibody and irinotecan |
| 02/08/2012 | EP2413938A2 Kinase protein binding inhibitors |
| 02/08/2012 | EP2413928A1 Use of flavonoids to increase the bioavailability of hesperetin |
| 02/08/2012 | EP2413920A1 Curcuminoids in combination docetaxel for the treatment of cancer and tumour metastasis |
| 02/08/2012 | EP2413916A2 Lyophilization cakes of proteasome inhibitors |
| 02/08/2012 | EP2150263B1 Plant extract and its therapeutic use |
| 02/08/2012 | EP2148874B1 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors |
| 02/08/2012 | EP1948242B9 Cytotoxic compounds |
| 02/08/2012 | EP1735013B1 Alpha- and beta-emitting hydroxyapatite particles |
| 02/08/2012 | EP1633365B1 Macrocyclic quinazoline derivatives as antiproliferative agents |
| 02/08/2012 | EP1537203B1 USE OF DENDRITIC CELLS (DCs) EXPRESSING INTERLEUKIN 12 (IL-12) |
| 02/08/2012 | EP1267924B1 Immunotherapeutic methods and compositions |
| 02/08/2012 | CN1652757B Edg受体结合剂在癌症中的应用 Edg receptor binding agents in cancer of the |
| 02/08/2012 | CN102348796A Novel cancer antigen eEF2 |
| 02/08/2012 | CN102348708A Prodrug forms of kinase inhibitors and their use in therapy |
| 02/08/2012 | CN102348707A Pyrimidinecarboxamide derivatives as inhibitors of SYK kinase |
| 02/08/2012 | CN102348702A Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof |
| 02/08/2012 | CN102348668A Compounds and uses thereof for treating inflammation and modulating immune responses |
| 02/08/2012 | CN102348461A Compositions and methods of use |
| 02/08/2012 | CN102344489A Modified sodium iodine symporter protein and application thereof |
| 02/08/2012 | CN102344482A Betulinol derivant, preparation method and usage |
| 02/08/2012 | CN102344476A Thymidine cyclophosphate compound and antitumor application thereof |
| 02/08/2012 | CN102344468A Preparation and use of novel AKT/PKB kinase agonists |
| 02/08/2012 | CN102344457A Spirocyclic aminoquinolones as gsk-3 inhibitors |
| 02/08/2012 | CN102344454A Wikstroemia indica (L.) C.A.Mey extract as well as preparation method and application thereof |
| 02/08/2012 | CN102344445A Optical voidness quinazoline compound |
| 02/08/2012 | CN102344444A Optically pure quinazoline compounds |
| 02/08/2012 | CN102344443A Open-loop maleimide compound utilizing click chemosynthesis and application in treating diseases thereof |
| 02/08/2012 | CN102344438A Crystals of quinoline derivative and preparation methods thereof |
| 02/08/2012 | CN102344398A 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 02/08/2012 | CN102344371A Temperature-sensing amphiphilic polyether dendrons and their preparation method and use |
| 02/08/2012 | CN102344365A Two novel compounds with antitumor effects in Rubus corchorifolius leaves, preparation method and application thereof |
| 02/08/2012 | CN102344351A Aryl-substituted chalcones compound, its preparation method and its application |
| 02/08/2012 | CN102343103A Screening and verifying of human papilloma virus (HPV) 16 tripeptide vaccine and construction of tumor animal model for continually expressing HPV16 E5, E6 and E7 |
| 02/08/2012 | CN102343101A Preparation method and application of functionalized kaolin nanotube-antisense oligonucleotide medicine carrier |
| 02/08/2012 | CN102343100A Method for quickly preparing rutin inclusion compound |
| 02/08/2012 | CN102343099A Preparation method and application of folacin mediated tumor targeting adriamycin prodrugs |
| 02/08/2012 | CN102343098A Functionalized magnetic nanoparticles and methods of use thereof |
| 02/08/2012 | CN102343096A Andrographolide cyclodextrin inclusion compound, preparation method and application thereof |
| 02/08/2012 | CN102343094A Compositions and methods of delivery of pharmacological agents |
| 02/08/2012 | CN102343092A Drug carrier and drug carrier kit for inhibiting fibrosis |
| 02/08/2012 | CN102343091A Ezrin phosphorylation-based material and application thereof |
| 02/08/2012 | CN102343089A A medical composition for treating breast cancer |
| 02/08/2012 | CN102343086A Drug and tumor whole-cell vaccine for treating or preventing tumor, and preparation methods and applications of drug and whole-cell vaccine |
| 02/08/2012 | CN102343079A Traditional Chinese medicine for treating cancerous fever of liver and gallbladder damp-heat type |
| 02/08/2012 | CN102343042A Medicine for treating cardiovascular diseases of hypertension, cardiopathy and cerebral thrombus |
| 02/08/2012 | CN102343040A Drug for treating otitis media, deaf and tinnitus |
| 02/08/2012 | CN102343038A Medicament for treating cerebrosis such as hemiplegic cerebral palsy, falling sickness, Parkinson, headache, insomnia and the like |
| 02/08/2012 | CN102343037A Drug with effects of bacterium resistance, disinfection, blood circulation promotion, blood stasis removal, immunity improvement, life prolonging and aging delay |
| 02/08/2012 | CN102343013A Camellia saponin controlled release tablet and preparation method thereof |
| 02/08/2012 | CN102342984A Novel use of coptis total alkaloid extract |
| 02/08/2012 | CN102342973A Extraction and enrichment method of total saponins from rhizoma bolbostemmae |
| 02/08/2012 | CN102342968A Healthcare and recovery medicine with human urine as main ingredient |